pyridinoline has been researched along with HIV Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fux, C; Piso, RJ; Rothen, JP; Rothen, M; Stahl, M | 1 |
| Piso, RJ; Rothen, JP; Rothen, M; Stahl, M | 1 |
2 other study(ies) available for pyridinoline and HIV Infections
| Article | Year |
|---|---|
Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients.
Topics: Administration, Oral; Amino Acids; Biomarkers; Bone Resorption; Calcifediol; Cholecalciferol; Female; HIV Infections; Humans; Male; Middle Aged; Vitamin D Deficiency | 2013 |
Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used.
Topics: Alkaline Phosphatase; Amino Acids; Anti-HIV Agents; Bone and Bones; HIV Infections; Humans; Osteoporosis | 2011 |